Cleveland Stock Future Price Prediction

CBLI -  USA Stock  

USD 4.30  0.06  1.38%

Cleveland Biolabs stock price prediction is an act of determining the future value of Cleveland Biolabs shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Cleveland Biolabs' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cleveland Biolabs and does not consider all of the tangible or intangible factors available from Cleveland Biolabs' fundamental data. We analyze noise-free headlines and recent hype associated with Cleveland Biolabs, which may create opportunities for some arbitrage if properly timed.
Continue to Cleveland Biolabs Basic Forecasting Models to cross-verify your projections.

Search Price Prediction 

It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Cleveland Biolabs based on different types of headlines from major news networks to social media. The Cleveland stock price prediction module provides an analysis of price elasticity to changes in media outlook on Cleveland Biolabs over a specific investment horizon. Using Cleveland Biolabs hype-based prediction, you can estimate the value of Cleveland Biolabs from the perspective of Cleveland Biolabs response to recently generated media hype and the effects of current headlines on its competitors.
Cleveland Biolabs Accounts Payable Turnover is most likely to increase in the upcoming years. The last year's value of Accounts Payable Turnover was reported at 11.84. The current Accrued Expenses Turnover is estimated to increase to 0.76, while Cash and Equivalents Turnover is projected to decrease to 0.46.
This module is based on analyzing investor sentiment around taking a position in Cleveland Biolabs. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Cleveland Biolabs to buy its stock at a price that has no basis in reality. In that case, they are not buying Cleveland because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cleveland Biolabs after-hype prediction price

  $ 4.27  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Cleveland Biolabs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Cleveland Biolabs in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
Band Projection (param)
LowerMiddle BandUpper
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cleveland Biolabs. Your research has to be compared to or analyzed against Cleveland Biolabs' peers to derive any actionable benefits. When done correctly, Cleveland Biolabs' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Cleveland Biolabs.

Cleveland Biolabs After-Hype Price Prediction Density Analysis

As far as predicting the price of Cleveland Biolabs at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cleveland Biolabs or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Cleveland Biolabs, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Cleveland Biolabs Estimiated After-Hype Price Volatility

In the context of predicting Cleveland Biolabs' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cleveland Biolabs' historical news coverage. Cleveland Biolabs' after-hype downside and upside margins for the prediction period are 0.21 and 9.38, respectively. We have considered Cleveland Biolabs' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2nd of August 2021
After-hype Price
Cleveland Biolabs is risky asset. Analysis and calculation of next after-hype price of Cleveland Biolabs is based on 3 months time horizon.

Cleveland Biolabs Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Cleveland Biolabs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cleveland Biolabs backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cleveland Biolabs, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.26  5.11  0.03   0.03  7 Events / Month4 Events / MonthIn about 7 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

Cleveland Biolabs Hype Timeline

Cleveland Biolabs is currently traded for 4.30. The entity has historical hype elasticity of -0.03 and average elasticity to hype of competition of -0.03. Cleveland is expected to decline in value after the next headline with price expected to drop to 4.27. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.7% whereas the daily expected return is currently at -0.26%. The volatility of related hype on Cleveland Biolabs is about 3992.19% with expected price after next announcement by competition of 4.27. About 50.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.18. Cleveland Biolabs next dividend is scheduled to be issued on the 29th of October 2010. The entity had 1:20 split on the 28th of January 2015. Given the investment horizon of 90 days the next expectedpress releasewill be in about 7 days.
Continue to Cleveland Biolabs Basic Forecasting Models to cross-verify your projections.

Cleveland Biolabs Related Hype Analysis

Having access to credible news sources related to Cleveland Biolabs' direct competition is more important than ever and may enhance your ability to predict Cleveland Biolabs' future price movements. Getting to know how Cleveland Biolabs rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cleveland Biolabs may potentially react to the hype associated with one of its peers.

Cleveland Biolabs Additional Predictive Modules

Most predictive techniques to examine Cleveland price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cleveland using various technical indicators. When you analyze Cleveland charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cleveland Biolabs Predictive Indicators

The successful prediction of Cleveland Biolabs stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cleveland Biolabs, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cleveland Biolabs based on analysis of Cleveland Biolabs hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cleveland Biolabs's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cleveland Biolabs's related companies.
 2020 2021 (projected)
PPandE Turnover39.3942.5
Long Term Debt to Equity0.01390.0138

Story Coverage note for Cleveland Biolabs

The number of cover stories for Cleveland Biolabs depends on current market conditions and Cleveland Biolabs' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cleveland Biolabs is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cleveland Biolabs' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Cleveland Biolabs Short Properties

Cleveland Biolabs' future price predictability will typically decrease when Cleveland Biolabs' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cleveland Biolabs often depends not only on the future outlook of the potential Cleveland Biolabs' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cleveland Biolabs' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out0.19%
Short Percent Of Float0.34%
Float Shares7.69M
Shares Short Prior Month90.83k
Average Daily Volume Last 10 Day183.37k
Average Daily Volume In Three Month230.06k
Date Short Interest28th of May 2021
Continue to Cleveland Biolabs Basic Forecasting Models to cross-verify your projections. Note that the Cleveland Biolabs information on this page should be used as a complementary analysis to other Cleveland Biolabs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Cleveland Stock analysis

When running Cleveland Biolabs price analysis, check to measure Cleveland Biolabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cleveland Biolabs is operating at the current time. Most of Cleveland Biolabs' value examination focuses on studying past and present price action to predict the probability of Cleveland Biolabs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cleveland Biolabs' price. Additionally, you may evaluate how the addition of Cleveland Biolabs to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Global Correlations
Find global opportunities by holding instruments from different markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
The market value of Cleveland Biolabs is measured differently than its book value, which is the value of Cleveland that is recorded on the company's balance sheet. Investors also form their own opinion of Cleveland Biolabs' value that differs from its market value or its book value, called intrinsic value, which is Cleveland Biolabs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cleveland Biolabs' market value can be influenced by many factors that don't directly affect Cleveland Biolabs underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cleveland Biolabs' value and its price as these two are different measures arrived at by different means. Investors typically determine Cleveland Biolabs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cleveland Biolabs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.